Phenyl (4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)carbamate CAS 184177-81-9 Posaconazole Intermediate High Quality

Short Description:

Chemical Name: Phenyl (4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)carbamate

CAS: 184177-81-9

Intermediate of Posaconazole (CAS 171228-49-2) Triazole Antifungal Agent

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Factory Supply with High Purity and Stable Quality
Posaconazole Related Intermediates Commercial Production
Posaconazole CAS 171228-49-2
Posaconazole Intermediate POA CAS 149809-43-8
Phenyl (4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)carbamate CAS 184177-81-9
1-(4-Aminophenyl)-4-(4-hydroxyphenyl)piperazine CAS 74853-08-0
2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazinecarboxal CAS 170985-85-0
Diethyl L-(+)-Tartrate CAS 87-91-2

Chemical Properties:

Chemical Name	Phenyl (4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)carbamate
Synonyms	Posaconazole Intermediate
CAS Number	184177-81-9
CAT Number	RF-PI290
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C23H23N3O3
Molecular Weight	389.45
Density	1.296
Shipping Condition	Under Ambient Temperature
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Pale Brown to Grey Powder
Purity / Analysis Method	≥99.0% (HPLC)
Loss on Drying	≤0.50%
Residue on Ignition	≤0.20%
Heavy Metals	≤20ppm
Single Impurity	≤0.50%
Total Impurities	≤1.0%
Test Standard	Enterprise Standard
Usage	Intermediate of Posaconazole (CAS 171228-49-2)

Package & Storage:

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

FAQ:

Application:

Phenyl (4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)carbamate (CAS 184177-81-9) is an Intermediate of Posaconazole (CAS 171228-49-2). Posaconazole is a broad-spectrum, second generation, triazole compound with antifungal activity. It was approved for medical use in the United States in September 2006, and is available as a generic medication. Posaconazole is a triazole antifungal drug marketed in the United States by Schering-Plough under the trade name Noxafil. Posaconazole works by disrupting the close packing of acyl chains of phospholipids, impairing the functions of certain membrane-bound enzyme systems such as ATPase and enzymes of the electron transport system, thus inhibiting growth of the fungi. It does this by blocking the synthesis of ergosterol by inhibiting of the enzyme lanosterol 14a-demethylase and accumulation of methylated sterol precursors.